Invasive non-typeable Haemophilus influenzae diseases in children.
The current approach to patients with invasive non-typeable H. influenza disease is based upon past experience with the type b strains. In areas where clinicians cannot obtain typing information in a timely manner, issues concerning treatment and prophylaxis should be approached as if the patients were infected with a type b strain. This approach will not change until further information becomes available on invasive non-typeable H. influenzae infections in children.
Schutze
G E
GE
Pediatrics and Pathology, UAMS, Arkansas Children's Hospital, USA.
Garrison
S F
SF
D002439:Cefotaxime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D005260:Female; D006192:Haemophilus Infections / Q000188:drug therapy / Q000382:microbiology*; D006193:Haemophilus influenzae / Q000145:classification* / Q000302:isolation & purification / Q000472:pathogenicity; D006801:Humans; D007223:Infant
D002511:Cephalosporins; D002439:Cefotaxime